Clinical trial on MMN ongoing at the Institute:
- ARGX-117-2002_ARDA: A Phase 2, Randomized, Double-Blinded, Placebo-Controlled, Parallel-Group, Multicenter Trial to Evaluate the Safety and Tolerability, Efficacy, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of 2 Dose Regimens of ARGX-117 in Adults With Multifocal Motor Neuropathy.
Acronym |
ARGX-117-2002_ARDA |
Intervention | ARGX-117 |
Principal investigator | K. Viala |
Sponsor | Argenx |
Study status | Ongoing |
Recruitment status | In preparation |
Population | Adult |
+ infos on clinicaltrials.gov |